Kodiak Sciences is a biopharmaceutical company focused on developing innovative therapies to treat retinal diseases. Founded in 2009, Kodiak Sciences is known for its novel antibody biopolymer conjugate platform, designed to enhance drug delivery to the eye and improve treatment outcomes for patients with conditions such as age-related macular degeneration and diabetic retinopathy. With a commitment to advancing ophthalmic care through cutting-edge research and development, Kodiak Sciences is poised to make a significant impact in the field of retinal disease treatment.

Refer new talent to Kodiak Sciences